Back to
Janus Henderson Group Ltd.
ANTX6 quarters
Position history for
Janus Henderson Group Ltd.'s holdings in AN2 THERAPEUTICS INC
No. Janus Henderson exited its ANTX (AN2 Therapeutics) position in Q3 2024. Its Q2 2024 13F listed 1,221,051 shares worth $2.6M. Janus Henderson first reported ANTX in Q2 2023 and held it in 5 quarterly 13F filings.
Final Value
$0
Final Shares
0
Total Value Change
-$8.6M
Total Shares Change
-1M
Quarter-by-Quarter History
Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.